Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Fred Sanger
- Sanger sequencing method
- X-ray film of DNA sequencing
- Fluorescent Sanger sequencing
- Fluorescent DNA image
- Point and in/del mutations
- Cost of sequencing the human genome
- Cost per genome
- What is this ‘next-gen’ sequencing?
- Characteristics of 'next-gen' sequencing
- 1. Bridge amplification
- 2. 'Polony' formation
- 3. Sequencing
- 4. Sequencing over multiple cycles
- Image of fluorescent signals
- Flow cells
- ‘Paired-end’ reads increase accuracy
- Multiplexing
- ‘Whole exome sequencing’
- Mosaic mutations
- Identifying genetic drivers in a specific cancer
- Prenatal diagnosis
- Identifying aneuploidy in chromosome 21
- RNA sequencing (RNAseq)
- Chromatin immunoprecipitation sequencing (ChIPseq)
- Summary
Topics Covered
- Sanger sequencing
- Fluorescent Sanger sequencing
- Whole genome sequencing
- Next generation sequencing
- Multiplexing
- Whole exome sequencing
- Transcriptome sequencing
- Chromatin immunoprecipitation sequencing
Links
Series:
Categories:
External Links
Talk Citation
Yeo, G. (2021, May 30). Genomics 101: an introduction to sequencing [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/FCIS5500.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Giles Yeo has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Introduction to Human Genetics and Genomics
Transcript
Please wait while the transcript is being prepared...
0:00
Hi, my name is Giles Yeo and I'm a geneticist based at the University of Cambridge.
This lecture is entitled 'Genomics 101: an Introduction to Sequencing'.
0:11
This is Fred Sanger, who passed away in 2013.
He won two Nobel prizes, because one is not enough.
In 1958, he won a Nobel Prize in Chemistry for protein sequencing of insulin
(that's determining all of the amino acids within the molecule of insulin),
but in 1980 he won his second Nobel Prize in Chemistry,
which was for nucleic acid sequencing.
Winning one Nobel Prize is enough, but winning two Nobel Prizes
and having come up with nucleic acid sequencing was a tremendous achievement,
so much so that the Sanger Institute down in the south of Cambridge
(which played a huge role in the Human Genome Project) is named after Fred Sanger.
0:52
The Sanger sequencing is important to understand, because it forms the basis
for how all of the current technologies of sequencing work,
even though it's not exactly the Sanger method any more.
I thought it would be worthwhile to spend a few minutes
explaining how the Sanger sequencing method works.
The Sanger sequencing method is a chain termination method,
using specific nucleotides called 'dideoxy terminators'.
When a dideoxy terminator of A, T, G,
or C binds, the DNA strand no longer extends.
In other words, when a dideoxy terminator binds
you end up with a stop, and that's it, it's stopped.
Say you have a fragment of DNA that you want to sequence, and you
put in the DNA polymerase and you put in the normal nucleotides,
but you titrate in some terminating nucleotides,
given Avogadro's number worth of DNA template,
suddenly you get a random incorporation of these terminating nucleotides
so that you end up with an entire library.
Because you start with so many fragments of template DNA,
and because there is a random incorporation of the terminating nucleotides,
you end up with a library of fragments representing
every single nucleotide that is there.
The original sequencing technologies used
radioactive dideoxy terminators such as A, T, G, or C which were radioactively labelled,
so when the terminating nucleotide was incorporated you could see it using X-ray.
You had to use four different tubes to distinguish between the radioactivity:
an A tube, a T tube, a G tube, a C tube.
Once you did the reactions you ran it out on a polyacrylamide gel, which was able to
distinguish differing single base-pair differences in length,
and you ended up with this ladder.
Reading from the bottom up,
the sequence would then be reading A-T-G-C-A-T-A-A, and so on.
Because you could tell the difference between every single fragment,
you were able to read the ladder of the DNA fragments going upwards.